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a  b  s  t  r  a  c  t
Diazinon  (DZN)  is an organophosphate  insecticide  which  exerts  its effect  through  the inhibition  of  acetyl-
cholinesterase  enzyme  (AChE).  In  this  work,  we studied  the  development  of  tolerance  to  subchronic  p.o.
administration  of DZN  in  rats, under  both  in  vivo  and in  vitro  conditions.  A group  of 20  rats  (2 groups,  n  =  10)
was administered  p.o.  the 1/10  of established  LD50 DZN  (namely  55.87  mg/kg  bw)  for  28 days.  On the  14th
and  28th  day  of  study  with  isolated  diaphragm  and  ileum,  we examined  the  downregulation  of  nicotinic
and  muscarinic  receptor  function  through  Electrical  Field  Stimulation  (EFS).  Maximum  contractility  of
the diaphragm  was  recorded  on the 14th  day  of the study  (25%  higher  compared  to the  non-treated  rats),
while  on  the  28th  day  the contractions  almost  did not  differ  from  the  values  found  in non-treated  rats.  EFS
of isolated  ileum  on  the  14th  day  of  study  caused  signiﬁcantly  higher  contractions  compared  to  the  non-
treated  rats,  but after  28  days,  ileum  contractions  decreased  approximately  to  the level  of  contractions
in  non-treated  rats.  On  the 14th  study  day,  we  also recorded  increased  amplitude  of  spontaneous  ileum
contractions,  compared  to non-treated  rats. The  application  of  increasing  ACh  concentrations  caused
dose-dependent  ileum  contractions,  without  statistically  signiﬁcant  differences  of  median  effective  con-eywords:
iazinon
ubchronic intoxication
FS
iaphragm
leum
centration  (EC50) values  in  non-treated  and treated  rats.  Tolerance  to subchronic  DZN  administration
develops  due  to various  adaptation  mechanisms,  including  the  most  important  one—downregulation  of
nicotinic  and  muscarinic  receptor  function.
© 2016  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ats
. Introduction
Diazinon (O,O-diethyl O-[4-methyl-6-(propan-2-yl) pyrimidin-
-yl] phosphorothioate) is an organophosphate insecticide with a
road spectrum of activity. Therefore, in the past it was used in agri-
ulture and horticulture worldwide for controlling insects in crops,
ruit and vegetables and as a pesticide in domestic, agricultural and
ublic buildings. Within Veterinary Medicine, DZN has been used
n ectoparasiticide formulations for sheep and cattle, and in collars
nd washes for external parasite control in companion animals [13].
∗ Corresponding author.
E-mail address: si34826@gmail.com (S.R. Ivanovic´).
ttp://dx.doi.org/10.1016/j.toxrep.2016.06.002
214-7500/© 2016 Published by Elsevier Ireland Ltd. This is an open access article under Poisoning of people and animals with DZN typically occurs
through the ingestion of contaminated food or water. When
diazinon gets into the body, through metabolic oxidative desul-
phurization and mediation of cytochrome P450 (CYP 450), the
sulphur is being replaced with oxygen, thus creating phosphoryl
compound—diazoxon, characterized by anticholinesterase activity
[22,29,5], leading to the accumulation of acetylcholine at nerve
endings, resulting in overstimulation of the cholinergic system
(nicotinic and muscarinic receptors) [4].
Overstimulation of nicotinic receptors results in the paral-
ysis of principal respiratory muscle-diaphragm, which is a
life-threatening condition. Taking this into account, the phrenic
nerve-diaphragm preparation [19] has been adopted as a common
model in the study of toxic effects of organophosphates, as well as
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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n the studies related to mice and rat diaphragm neuromuscular
ynapse [2,24,38,41,34].
However, a signiﬁcant limitation of this method is that phrenic
erve must be intact; and therefore it is not applicable to
iaphragms of large animal species or to diaphragm biopsies. The
lternative method relies on EFS, with diaphragm samples contain-
ng only intramuscular branches of phrenic nerve [42].
The EFS reevaluation has been described by Seeger et al. [36].
FS method may  be used for two stimulation types of diaphragm
amples: indirect stimulation – induced by the activation of post-
ynaptic nicotinic acetylcholine receptors (nAChR) through the
elease of ACh neurotransmitter, and direct stimulation – directly
ctivating the contractile machinery of the muscle.
The overstimulation of muscarinic receptors (M3 subtype)
auses bronchoconstriction, airway hyper-reactivity and bronchial
ucus overproduction [11]), resulting in severe clinical picture of
oisoning with organophosphate compounds. It is well known that
3 subtype of muscarinic receptors is also found in smooth airway
nd ileum muscles [7] and a primary role of the receptors is to
ontract smooth muscles [26], as well as to regulate the activity of
any glands, both endocrine and exocrine. Therefore, an isolated
at ileum may  be used as a muscarinic receptor model for the study
n toxic effects of organophosphates.
Having in mind relatively short DZN half-time and a risk of mis-
nterpretation of laboratory data related to AChE activity (still a
gold” standard in diagnosing organophosphate poisoning), as well
s nonspeciﬁc clinical manifestations of DZN poisoning, the aim of
his study was to examine the EFS method as a potential tool for
he diagnostic of DZN poisoning.
. Material and methods
.1. Animals
All animal procedures were conducted in accordance with the
irective 2010/63/EU on the protection of animals used for study
nd other scientiﬁc purposes and approved by the Ethical Commit-
ee of the Faculty of Veterinary Medicine of Belgrade University.
In vivo tests (determination of LD50 values) and in vitro tests
on isolated diaphragm and ileum) were conducted on a total of
10 white male Wistar rats, weighing 200 ± 20 g. The rats were
oused under standard conditions for laboratory animals, on a
2 h light/dark cycle, at room temperature 21–24 ◦C, and ad libitum
ccess to standard diet and water.
.2. Substances and methods of administration
For in vivo tests, we used technical DZN (Makhteshim Chemical
orks Ltd., Israel) minimum purity 95%, and corn oil as a solvent
f DZN (cold-pressed oil from corn germs) (Uvita, Serbia). During
n vivo tests, DZN was orally administered to rats, using a stiff gastric
onde (75 mm length) (Hauptner, Switzerland). Maximum volume
dministered p.o. did not exceed 0.1 ml/100 g of rat bw.
For in vitro tests on isolated rat diaphragm and ileum we
sed: mecamylamine hydrochloride (Sigma-Aldrich, St. Louis, MO,
SA), pancuronium bromide (Sigma-Aldrich, Germany), atropine
ulphate (Sigma-Aldrich, St. Louis, MO,  USA), acetylcholine (Sigma-
ldrich, St. Louis, MO,  USA) and distilled water as a solvent. The
rgan bath was ﬁlled with aerated Tyrode’s solution (125 mM
aCl, 24 mM NaHCO3, 0.4 mM NaH2PO4, 5.4 mM KCl, 1 mM MgCl2,
.8 mM CaCl2, 10 mM Glucose, 95% O2, 5% CO2, pH 7.4), and tem-
erature was maintained at 37 ◦C. The substances were applied to
solated organ bath through 1 ml  syringe marked in hundredths.eports 3 (2016) 523–530
2.3. Procedures
2.3.1. Determination of acute oral toxicity (LD50) of DZN in rats
The testing was  conducted on 30 rats, divided into 4 equal
experimental groups of 6 rats each, and the control one. DZN was
administered p.o., in single doses ranging from 400 to 700 mg/kg of
rat bw.  Control rats were dosed once with 0.1 ml/100 g of bw DZN
solvent (corn oil). The mortality of treated rats was monitored on
daily basis for 7 days after the administration.
2.3.2. Determination of acute oral toxicity (LD50) of DZN in rats
treated for 28 days with 1/10 LD50
The study included 50 rats, divided into 4 equal experimental
groups (of 10 rats each) and the control one. DZN was  administered
p.o. for 28 consecutive days at 1/10 LD50. Control rats were orally
administered only DZN solvent (corn oil) at 0.1 ml/100 g bw. After
28 days of treatment, survived rats were randomized into four new
experimental groups of 6 rats each, in order to determine the value
of LD50. DZN was  then administered in doses ranging from 500 to
800 mg/kg bw. The mortality of all treated rats was monitored on
daily basis for 7 days after the administration.
Two determined LD50 DZN values (LD50 in non-treated rats and
LD50 in rats treated for 28 days with 1/10 LD50) were analysed and
compared in the Results and the Discussion section.
2.3.3. Study of DZN effects on isolated rat diaphragm and ileum
The study was conducted on 30 rats, divided into two experi-
mental groups (n = 10) and the control one. DZN was administered
p.o. at 1/10 of acute LD50, for 28 days. Control rats were orally
administered DZN solvent (corn oil) at 0.1 ml/100 g bw.  At the end
of the treatment period, on the 14th day (group 1) and the 28th
day (group 2), 6 rats were randomly selected from both groups
and euthanized with an overdose of pentobarbitone. Diaphragms
and appropriate ileum segments from sacriﬁced rats were removed
immediately, for further in vitro study.
The diaphragm preparation for in vitro study was arranged as
described by Trailovic´ et al. [40]. Diaphragm hemispheres were
quickly excised and cut into strips of 1 × 0.5 cm, with incisions
parallel to the direction of muscle ﬁbres. Strips were mounted hori-
zontally in an organ bath (with aerated Tyrode’s solution), such that
one end was  ﬁxed to the bath base, and the other end attached to
isometric force transducer, connected to SmartPlus 50 software (El
Unit, Serbia). With a pair of platinum electrodes placed parallel to
the muscles, EFS was  performed by applying tetanic pulses (50 Hz
frequency, 25 V voltage, width 15 s, and 2 s duration) in trains of
ﬁve pulses every 30 s, with rest interval of 3 min  in between.
The preparation from isolated rat ileum was made of pre-
terminal part of ileum. A sample of 4–5 cm length was taken at
approximately 10 cm from ileocecal valve, and placed into Tyrode’s
solution. After removal of fatty tissue, an intestine segment (2 cm
length) was placed into organ bath ﬁlled with Tyrode’s solution,
warmed to the temperature of 37 ◦C, pH value 7.4. Oxygenation
of Tyrode’s solution in organ bath was performed by mixing oxy-
gen and carbon dioxide (95% + 5%, respectively). Similar as with the
diaphragm, one end of ileum was  ﬁxed to the bath base, and the
other end attached to isometric force transducer, so that the ileum
segment was  located centrally between the two  electrodes. Plat-
inum electrodes were placed on the sides of the preparation at a
distance of 3–4 mm and connected with stimulator BioSmart 150
(El Unit, Serbia). EFS was  performed by applying pulses (50 Hz, 35 V,
2 s and 2 s) in trains of ﬁve pulses every 60 s. After rest interval of
3 min, the same ileum segment was injected with increasing doses
of acetylcholine (0.1, 0.3, 1, 3 and 10 M),  in order to determine the
dose-response effect. Spontaneous ileum activity, its contractions
logy Reports 3 (2016) 523–530 525
i
t
2
a
t
t
[
t
d
t
t
t
a
t
4
3
3
t
d
g
o
C
c
t
a
ﬁ
w
t
L
f
r
a
t
m
r
t
s
s
c
c
t
a
d
r
2
T
d
g
f
o
b
0
10
20
30
40
50
60
70
80
90
100
100001000100
E
ff
ec
t (
%
)
Diazinon (mg/kg)
non-treated rats
rats treated 28 days 
Fig. 1. Dose-response curves of DZN lethal effects in non-treated rats
(LD50 = 558.70 mg/kg) () and in rats treated for 28 days with 1/10 LD50
(LD50 = 660.25 mg/kg) (O).
Fig. 2. Contractions of diaphragm strips (g) isolated from non-treated rats, induced
by  EFS (50 Hz, 25 V, 15 s, 2 s) and the effect of mecamylamine (100 M) on theS.R. Ivanovic´ et al. / Toxico
nduced by EFS and ACh level increase, were recorded by isometric
ransducers and BioSmart 150 software (El Unit, Serbia).
.4. Statistical analysis
DZN median lethal dose (LD50) was calculated by probit analysis
ccording to the method of Litchﬁeld and Wilcoxon I, and the rela-
ive potency between the two lethal doses LD501/LD502, according
o the method of Litchﬁeld and Wilcoxon II Tallarida and Murray,
37]).
Acetylcholine median effective doses (ED50) for ileum contrac-
ions in both non-treated and 1/10 LD50 DZN treated rats were
etermined by nonlinear regression and the differences between
hem tested with the F-test.
Statistical differences between the contractions of ileum and
he diaphragm isolated from both non-treated and 1/10 LD50 DZN
reated rats (on the 14th and 28th day), were analyzed by ANOVA
nd unpaired t-test.
Statistical analyses were performed by using commercial statis-
ical software Pharm/PCS, Version 4.0 and GraphPad Prism, Version
.0.
. Results
.1. Acute oral LD50 DZN in non-treated rats and 1/10 LD50 DZN
reated rats for 28 days
Through the application of method Litchﬁeld and Wilcoxon I, we
etermined acute oral LD50 DZN value of 558.70 mg/kg (safety mar-
ins from 475.69 to 656.19 mg/kg). DZN poisoning symptoms in rats
ccurred 2–3 h after the administration, depending on applied dose.
linical picture of acute poisoning was dominated by classic mus-
arinic effects, excessive lacrimation and salivation (concluded on
he base of wet  and stringy hair around medial eye corners, mouth
nd ventral neck area). The following symptoms also occurred: dif-
culty breathing, pulsing cross-striated muscles, difﬁculty moving,
ith consequent gathering and resting. Another signiﬁcant symp-
om was diarrhea.
Based on LD50 value, as determined in the previous section, 1/10
D50—55.8 mg/kg bw, was p.o. administered to a new group of rats,
or 28 consecutive days. Clinical picture and the mortality of treated
ats were monitored on daily basis.
First, the above mentioned, symptoms of DZN poisoning
ppeared on the 6th day from the beginning of administra-
ion. Almost all of treated rats developed behavioural changes,
anifested through resting, gathering and loss of interest in envi-
onment. Soon after, in parallel with these changes, appeared
he ﬁrst symptoms of cholinergic hyperactivity—lacrimation and
alivation, as well as difﬁculty breathing. Rats with most severe
ymptoms soon after experienced diarrhea, tremor of skeletal mus-
les, leading to ﬁrst lethal outcomes. This was also the pattern of
linical symptoms in other rats that died afterwards. After the 15th
reatment day, clinical symptoms of poisoning disappeared and the
nimals restored physiological conditions. Treated rats started to
ie on 7th and stopped on 14th day. Thirteen of 40 DZN treated
ats died.
Upon the completion of treatment with 1/10 LD50 DZN for
8 days, survived rats were prescribed with acute p.o. LD50.
hrough the application method of Litchﬁeld and Wilcoxon I, we
etermined acute oral LD50 DZN value of 660.24 mg/kg (safety mar-
ins from 577.06 to 755.42 mg/kg).As Fig. 1 shows, sigmoid curve of LD50 DZN values in rats treated
or 28 days with 1/10 LD50 shifted to the right in relation to the curve
f LD50 in non-treated rats. According to this study, the difference
etween calculated LD50 values was over 100 mg/kg bw, but thecontractions (±SEM); W—wash.
(**p = 0.0024 statistically signiﬁcant difference compared to non-treated rats)
potency value of 0.84 did not reach statistical signiﬁcance (safety
margins from 0.68 to 1.04).
3.2. Contraction of isolated rat diaphragm
We used the antagonists of nAChR—mecamylamine (100 and
300 M)  and pancuronium (2 M),  in order to prove that EFS
technique induced muscle contractions only across neuromuscular
end-plate.
Fig. 2 demonstrates average contraction values of diaphragm
preparations from non-treated rats induced with EFS, as well as
the effect of 100 M mecamylamine on the contractions.
Fig. 3 shows representative records of diaphragm preparation
contractions from non-treated rats, induced by EFS, as well as the
effect of mecamylamine (100 M)  on the contractions.
Considering the fact that the effect of 300 M mecamylamine
was tested only on four diaphragm preparations, this part of study
was not statistically analysed. However, obtained results indicated
that 300 M of mecamylamine completely blocked diaphragm con-
tractions induced by EFS (data not shown).
On the 14th day of oral administration of 1/10 LD50 DZN to the
rats, diaphragm preparations from treated rats were stimulated
with the same EFS parameters as the diaphragms from non-treated
rats. Inhibition of nicotinic receptors, previously produced with
100 M mecamylamine (data not shown), was reproduced with
pancuronium which is demonstrated at Figs. 4 and 5.
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mecamylami ne  
100 μM 
1 g 
1 min EFS 
W
Fig. 3. Representative recording of diaphragm strip contractions (g) from non-
treated rats induced by EFS (50 Hz, 25 V, 15 s, 2 s) and the effect of mecamylamine
(100 M)  on the contractions; W—wash.
Fig. 4. Contractions of diaphragm strips (g) isolated from rats on the 14th day of
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Table 1
Comparison of average diaphragm contraction values (g) induced by EFS (50 Hz,
25  V, 15 s, 2 s) from non-treated rats and rats treated with 1/10 LD50 DZN for 14
and 28 days (±SEM).
non-treated (n = 6) DZN 14 days (n = 6) DZN 28 days (n = 6)
1.33 ± 0.19 1.78 ± 0.12 1.36 ± 0.16
F
2reatment with 1/10 LD50 DZN induced by EFS (50 Hz, 25 V, 15 s, 2 s) and the effect
f  2 M pancuronium on the contractions (±SEM); W—wash.
***p = 0.0009 statistically signiﬁcant difference compared to non-treated rats)
The effect of pancuronium also conﬁrms indirect stimulation of
iaphragm, occurring at neuromuscular synapses through nAChR
Fig. 5).
On the 28th day of oral administration of 1/10 LD50 DZN, we
xamined diaphragm contractions. In this part of study we did not
est the effects of mecamylamine and pancuronium, but we mon-
tored the level of diaphragm contractions and compared it with
iaphragm contractions from non-treated rats and rats treated for
4 days with 1/10 LD50 DZN. The results of this comparison are
hown in Table 1 and Fig. 6.
The highest average level of diaphragm contractions induced
y EFS was recorded in the preparations isolated from rats treated
ith DZN for 14 days. The contractions were in average for 0.4 g (or
pancuro nium  
2 μM  
W
EFS 
1g 
1 min 
ig. 5. Representative recording of diaphragm strip contractions (g) isolated from rats on
 s) and the effect of 2 M pancuronium on the contractions; W—wash; direct EFS (50 HzFig. 6. Comparison of the main values of diaphragm contractions (g) induced by EFS
(50 Hz, 25 V, 15 s, 2 s) isolated from non-treated rats and rats treated for 14 and
28  days with 1/10 LD50 DZN (±SEM).
by 25%) higher than contractions of diaphragms isolated from non-
treated rats and rats treated with DZN for 28 days. Contractions
of diaphragms from non-treated rats and those treated 28 days
p.o. with DZN showed approximately the same values. Changes
recorded in this study did not reach statistically signiﬁcant level,
but due to apparent differences and consistency of results, the
changes will be considered under the Discussion section.
3.3. Contractions of isolated rat ileum
We  evaluated EFS induced contractions of isolated rat ileum and
amplitudes of spontaneous ileum contractions. We used (1 M)
atropine – antagonist of muscarinic receptors – in order to prove
that EFS technique induces smooth-muscle contractions of ileum
only through the activation of muscarinic receptors.
As Fig. 7 shows, statistically signiﬁcant difference (p = 0.0010)
compared with non-treated rats was recorded only in ileum prepa-
rations from rats treated for 14 days.
The same ileum preparations were also used to measure the
amplitude of spontaneous contractions. Fig. 8 shows that after
14 days of DZN treatment, the amplitude of spontaneous contrac-
tions in treated rats increased comparing with non-treated rats,
but this difference did not reach statistically signiﬁcant level. Two
weeks later, on the 28th treatment day, the amplitude level slightly
decreased.
W
d i r e c t   EFS 
pancuronium  
2 μM  
 the 14th day of treatment with 1/10 LD50 DZN induced by EFS (50 Hz, 25 V, 15 s,
, 25 V, 500 s, 2 s) and absence of 2 M pancuronium effect on the contractions.
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Fig. 7. Comparison of the main values of ileum contractions (g) induced by EFS
(50 Hz, 35 V, 2 s and 2 s) isolated from non-treated rats and rats treated with 1/10
LD50 DZN for 14 days and 28 days (±SEM).
(***p = 0.0010—statistically signiﬁcant difference comparing with non-treated)
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cig. 8. The amplitudes of spontaneous contractions of ileum (g) isolated from non-
reated rats and rats treated with 1/10 LD50 DZN for 14 and 28 days (±SEM).
Differences in amplitudes of ileum spontaneous contractions
orrespond to the differences in ileum contractions induced by EFS,
t the same time intervals (Figs. 7 and 8).
We also tested the effect of increasing concentrations of acetyl-
holine on contractility of ileum isolated from non-treated rats
nd the rats treated orally for 14 and 28 days with 1/10 LD50 DZN.
dministered ACh doses caused dose-dependent contractions in all
ested ileum preparations. Fig. 9 shows representative recordings
f the contractions of isolated ileum from rats treated with 1/10
D50 DZN for 14 days.Dose-dependent effects upon ileum contractions induced by
ncreasing doses of acetylcholine were determined by nonlinear
egression method. Table 2 and Fig. 10 show obtained results.
a) 
b) 
ACh 
0.1μM 
0.3μM 
1.0μM 
3.0μM 
10.0μM 
EFS 
W 
W 
1g 
1 min 
c) 
ig. 9. Representative recordings of (a) isolated rat ileum contractions (g) (rats treated w
b)  dose-dependent ileum contractions caused by increasing concentrations of ACh; W—w
ontractions of isolated rat ileum induced by EFS; W—wash.Fig. 10. Dose-response curves of ACh effect on the contractions of ileum (g) isolated
from non-treated rats and rats treated with 1/10 LD50 DZN for 14 and 28 days.
EC50 acetylcholine levels in non-treated and treated rats did
not differ signiﬁcantly. The lowest level of EC50 acetylcholine was
detected in ileum preparations from rats treated for 28 days and it is
interesting that the highest EC50 level was detected in ileum of rats
treated for 14 days. However, signiﬁcantly highest contractions,
as well as the highest maximum effect determined by nonlinear
regression, were detected in ileums of rats treated for 28 days. The
highest Hillslope was  at sigmoid curve of relation between dose
and effect on ileum of rats treated for 14 days.
4. Discussion
According to our knowledge, this study represents the ﬁrst
electrophysiological proof of downregulation of nicotinic and
muscarinic receptors, as one of the adaptation mechanisms to
subchronic/chronic intoxication with DZN, conﬁrmed by the appli-
cation of state-of-the-art EFS method.
In the DZN intoxication, as a consequence of AChE inhibition,
ACh neurotransmitters are being accumulated in overstimulatedreceptors resulted in diaphragm paralysis, and hyperstimulation
of muscarinic receptors caused spasm of respiratory airways and
hypersecretion of respiratory mucous, which is a life threaten-
d) 
atropine 
1 μM
W 
ith 1/10 LD50 DZN for 14 days) induced by EFS (50 Hz, 35 V, 2 s and 2 s); W—wash
ash (c) ileum contractions (g) induced by EFS and (d) 1 M atropine effect on the
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Table 2
EC50 (M) ACh levels, maximum effect (g) and Hillslope of ileum contractions caused by increasing concentrations of ACh from non-treated rats and rats treated orally for
14  or 28 days with 1/10 LD50 DZN (CI 95%).
non-treated (n = 6) treated 14 days (n = 6) treated 28 days (n = 6)
EC50 1.12 1.20 0.91
(0.60–2.08) (1.06–1.37) (0.18–4.60)
Max  effect 1.55 2.86 3.49
(1.38–1.72) (2.74–2.99) (2.87–4.12)
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(0.09–1.76)
ng condition for intoxicated organism. Because of this, after we
onﬁrmed in vivo the tolerance development to subchronic intox-
cation with DZN, we also conducted in vitro study on isolated
iaphragm, as a nicotinic receptor model and on isolated rat ileum,
s a muscarinic receptor model. In this part of the study, the
lectrophysiological results shown that signiﬁcant role in toler-
nce development to subchronic intoxication with DZN, plays also
ownregulation of nicotinic and muscarinic receptors, with possi-
le activation of some other adaptation mechanisms.
The literature acknowledges several different mechanisms
f tolerance development to chronic organophosphate intoxi-
ation. The one of them is downregulation of nicotinic and
uscarinic receptors [3,10,8,6]. Downregulation of nicotinic and
uscarinic receptors has been proved mostly quantitatively,
ased on the binding of -bungarotoxin (nAChR antagonist)
3,23,1,27] and quinuclidinyl benzilate (muscarinic receptor antag-
nist) [45,21,9,31,14].
In the determination of acute oral LD50 DZN, administered
oses induced dose-dependent lethality in rats and based on
ur results, acute p.o. LD50 DZN amounts to 558.7 mg/kg bw.  The
D50 DZN complies with the literature values for rats ranging
p to 600 mg/kg bw ([39] Toxicological proﬁle for Diazinon US
epartment of Health and Human Services, www.atsdr.cdc.gov/
oxproﬁles/tp86.pdf). Poisoning symptoms onset time and clinical
icture of acute organophosphate poisoning, characterized by mus-
arinic, nicotinic and CNS effects, are also consistent with literature
ata [32,17].
In rats treated for 28 days with 1/10 of previously determined
D50 DZN, ﬁrst symptoms appeared on the 6th day, after cumu-
ative dose of 6/10 LD50. The manifested behavioural changes
decreased movement, loss of interest in environment) pointed
o CNS function disorder. Soon after, hyperlacrimation and hyper-
alivation appeared, followed by muscle fasciculations. In the next
ew days, after the onset of diarrhea and few fatal issues, the clin-
cal picture of poisoning was complete. In the further course of
ur study, we would emphasize the ﬁnding that until the 15th
ay, all the above mentioned clinical symptoms disappeared. Until
he last day of the study (day 28th), treated rats restored physi-
logical balance and it was not possible to notice any difference
etween treated and non-treated animals. As such, the ﬁnding that
ymptoms like hypersalivation, hyperlacrimation, muscle fascicu-
ations and diarrhea, disappear with prolonged administration of
rganophosphates, complies with ﬁndings of Milatovic´ and Det-
barn [28]. The authors treated rats with paraoxon at 0.12 mg/kg bw
≈50% LD50) for 20 consecutive days. Cholinergic hyperreactivity
ccurred after the 4th application, sustained until the 10th appli-
ation and then disappeared, despite the fact that AChE activity
as reduced. The authors explained this phenomenon by de novo
ChE synthesis, which in tolerant rats increased the afﬁnity for
Ch; thereby the enzyme compensates for its signiﬁcantly lower
oncentrations with more efﬁcient ACh hydrolysis.
During the 28 days of treatment with 1/10 LD50 DZN, thirteen of
0 treated rats died (32.5%). As opposed to our results, within the
tudy conducted by Milatovic´ and Dettbarn [28] no rat died dur-2.65 0.48
(1.45–3.86) (−0.18 to 1.14)
ing 20 days of s.c. administration of organophosphate paraoxon at
≈50% LD50 per day. This difference could be partially explained by
different administration method, as well as by the effect of differ-
ent DZN toxicokinetics. Toxicokinetics of DZN after p.o. application
is such that DZN is rapidly absorbed from the gastrointestinal tract
and widely distributed throughout the body in both humans [33]
and animals [20,30]. Both human and animal data demonstrate
rapid metabolism of DZN and its oxon to DEP, DETP, and IMHP,
which are predominantly excreted in the urine [13,25,30,33,43,44].
However, although it is generally thought that organophosphorous
pesticides do not accumulate in the organism, being rapidly metab-
olized to their dialkylphosphates, Garcia-Repetto et al. [12] have
found an endogenous reintoxication caused by this kind of com-
pound. It is probably due to a release of the compound to blood
from a prior deposit of it in adipose tissue. Garcia-Repetto et al. [12]
reported detectable levels of DZN in blood, adipose tissue, muscle,
liver, and brain of Wistar rats following oral dosing at 23.33 mg/kg.
Olive oil was  used as a vehicle (we used corn oil as a vehicle).
In blood, adipose tissue, and brain, the levels of DZN decreased
with time from 4 to 20 days postdosing. Levels in liver and mus-
cle increased up to 8 and 12 days postdosing, respectively, and
decreased thereafter. By 30 days postdosing, detectable levels were
no longer observed in blood, adipose tissue, muscle, liver, or brain.
Considering the fact that our experimental conditions were very
similar to those in previous examinations and that we  used higher
p.o. dose (55.87 mg/kg bw), we may  thus conclude that the daily
DZN dose produced cumulative effect in organism. According to
our study protocol, on the 13th treatment day, when the last death
occurred, treated rats received cumulative dose by 30% higher than
LD50 and only one rat died. Until the end of the study, rats cumu-
latively received almost three times higher LD50 DZN dose and no
rat died. Described phenomena undoubtedly point to the develop-
ment of tolerance to DZN toxic effects, conﬁrmed by dose-response
curve shifted to the right in rats treated for 28 days with 1/10 LD50
DZN (see Fig. 1).
In order to precisely explain the observed tolerance develop-
ment to subchronic intoxication with DZN, we conducted in vitro
studies on diaphragm and ileum isolated from treated rats by EFS
method. EFS produced stable indirect contractions of diaphragm,
as a sole consequence of nAChR activation at motor end-plate
of neuromuscular junction. This was conﬁrmed using nAChR
antagonists—mecamylamine and pancuronium, both of which sig-
niﬁcantly blocked diaphragm contractions (Figs. 3 and 5). After the
pulse-width modiﬁcation from 15 to 500 s, mecamylamine and
pancuronium had no effect; therefore the occurred contractions
were induced by direct stimulation of muscle contractile machin-
ery (Fig. 5). With regard to the above, similar results were obtained
by Seeger et al. [36], who  conﬁrmed the indirect EFS of diaphragm
by the application of pancuronium.
In rats treated for 14 days with low DZN dose, average values of
diaphragm contractions induced by EFS were over 25% higher than
in non-treated rats, although the difference did not reach statistical
signiﬁcance (Table 1, Fig. 6), which indicated decreased AChE activ-
ity. We spectrophotometrically determined lowest AChE activity
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n erythrocytes (RBC AChE) and diaphragm on the 14th treatment
ay, and on the 28th day, the AChE activity was signiﬁcantly sta-
istically higher (p < 0.001) comparing to the value on the 14th
ay. However, these ﬁndings are not presented under Results sec-
ion. On the 28th treatment day, diaphragm contractions decreased
o control values which matched with the “recovery” of enzyme
ctivity, and together with nAChR downregulation, resulted in the
bsence of signiﬁcant changes in diaphragm contractile response.
s such, our electrophysiological ﬁndings comply with the results
btained by the application of other study methods proving tol-
rance development on the level of neuromuscular diaphragm
unctions and other cross-striated muscles (m. soleus, m. exten-
or digitorum longus)  after chronic exposure of rats to reversible
neostigmine) and irreversible (DFP) AChE inhibitors [3,15,16,1].
Fourteen days after the administration of low DZN doses, con-
ractions of ileum preparation were signiﬁcantly higher comparing
o non-treated rats (Fig. 7). Such a phenomenon could be explained
y increased sensitivity of ileum to ACh, which complies with the
esults of Foley and McPhillips [10] and Hayashi et al. [18]. These
uthors proved that prolonged administration of sublethal doses
f organophosphates induces apparent clinical symptoms of poi-
oning, leading to increased sensitivity of ileum to ACh. However,
ver the next two weeks ileum contractions reduced, and on the
8th treatment day, they were slightly higher than in control group
Fig. 7). We  attributed the decrease in ileum preparation sensitivity
o EFS stimulation to the downregulation of muscarinic recep-
ors, which complies with previous ﬁndings [10,6,35]. On the same
leum segments, we also measured the amplitudes of spontaneous
ontractions. They were slightly higher than control values on the
4th treatment day (Fig. 8).
In addition to EFS application, in order to study tolerance
evelopment, we also examined the effect of exogenously applied
ncreasing ACh concentrations to ileum contractions. Obtained EC50
Ch values did not differ signiﬁcantly (Table 2). The lowest value
f EC50 (0.91 M)  was recorded in ileum preparations after 28 days
f treatment, which pointed to the highest ACh sensitivity exactly
ithin this group. The supporting fact is that the highest maximum
ffect of ileum contractions was recorded exactly in rats treated for
8 days with diazinon (Fig. 10). Relatively different results of ileum
ontractions induced by EFS (sensitivity increased until the 14th
ay, then decreased until the 28th day), as well as by the outward
pplication of increasing ACh concentrations, are deﬁnitely the con-
equence of adaptation mechanisms related only to endogenous
tructures of the myenteric plexus.
In conclusion, considering the fact that EFS could be applied
o diaphragm biopsies from large animal species (ante mortem),
s well as to the organs of small animals (after autopsy), the
esults of our study could be useful in forensic diagnostics of
rganophosphate poisoning. This is particularly important if we
ave in mind the complexity of organophosphate poisoning diag-
ostics. There are no standardized tests for prompt detection of
rganophosphates and/or their metabolites in urine and blood
erum. Further, a wide variation in normal cholinesterase values
xists and there are no studies reporting a quantitative association
etween cholinesterase activity levels and exposure to diazinon.
hus, cholinesterase inhibition is not a speciﬁc biomarker of effect
or diazinon exposure, but is indicative only of effect, and not useful
or dosimetric analysis. Obtained results regarding AChE activity in
BC and diaphragm were in compliance with the results obtained
hrough EFS technique—when diaphragm contractions were the
ighest, the activity of RBC ACh and diaphragm was  the lowest. In
his context, we consider that EFS technique in combination with
nalysis of reductions in the level of RBC AChE activity and clin-
cal manifestations of poisoning characterized by a collection of
holinergic signs and symptoms, could contribute to more reliable
iagnostics of poisoning with organophosphate compounds.
[eports 3 (2016) 523–530 529
Nevertheless, having in mind that this study was conducted with
rats as test animals, further studies require to be made on large
animal samples and domestic animals.
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